ADULT ACUTE MYELOMONOCYTIC LEUKEMIA

Clinical trials for ADULT ACUTE MYELOMONOCYTIC LEUKEMIA explained in plain language.

Never miss a new study

Get alerted when new ADULT ACUTE MYELOMONOCYTIC LEUKEMIA trials appear

Sign up with your email to follow new studies for ADULT ACUTE MYELOMONOCYTIC LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 2 Completed 1

Could a targeted drug keep AML in check?

Disease control Completed

This phase III trial tests whether the drug tipifarnib can prevent acute myeloid leukemia (AML) from coming back in patients who are already in remission. Participants include adults over 60 in first remission, those in second or later remission, or those who achieved remission a…

Matched conditions: ADULT ACUTE MYELOMONOCYTIC LEUKEMIA

Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Jun 27, 2026 14:02 UTC

ADULT ACUTE MYELOMONOCYTIC LEUKEMIA

Get alerted when new ADULT ACUTE MYELOMONOCYTIC LEUKEMIA trials appear

Could a targeted drug keep AML in check?